Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Head and Neck Cancer

Free Subscription 16.11.2026 1 Am J Surg 11 BMC Cancer 1 BMC Surg 1 Clin Cancer Res 2 Clin Nucl Med 3 Dis Esophagus 21 Head Neck 2 Hum Pathol 1 Int J Radiat Oncol Biol Phys 2 J Clin Oncol 1 J Laryngol Otol 1 J Nucl Med 27 Oral Oncol 3 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. LONG SA, Satyadi MA, Pratt CG, Whitrock JN, et al
   To operate or not to operate: Clinical and sociodemographic determinants of provider advised non-surgical management for thyroid cancer.
   Am J Surg. 2026;262:117292.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. LI R, Cao S, Liu X, Zhao L, et al
   SLC3A2 identified as a new therapeutic target for head and neck squamous cell carcinoma.
   BMC Cancer. 2026;26:1363.
   PubMed         Abstract available
   
   
3. ZHANG X, Liu F, Wang W, Peng C, et al
   Prognostic significance of systemic inflammatory and peripheral immune profiles in differentiated thyroid carcinoma: a retrospective cohort study.
   BMC Cancer. 2026;26:1364.
   PubMed         Abstract available
   
   
4. E SILVA DKV, da Silva RO, Silva SVA, Raymundo MLB, et al
   Financial toxicity in patients with head and neck cancer: a scoping review.
   BMC Cancer. 2026;26:1365.
   PubMed         Abstract available
   
   
5. YANG Y, Liu W, Xu Y, Peng X, et al
   Geriatric nutritional risk index and prognosis in middle-aged and elderly patients with nasopharyngeal carcinoma.
   BMC Cancer. 2026;26:1372.
   PubMed         Abstract available
   
   
6. SUMAZAKI M, Yajima S, Ito M, Suzuki T, et al
   Serum anti-POTEE antibodies as a novel serological biomarker for early detection and prognostic stratification in gastrointestinal cancers.
   BMC Cancer. 2026;26:1377.
   PubMed         Abstract available
   
   
7. WANG W, Ding T, Liu C, Hong X, et al
   A cfDNA fragmentomics-based liquid biopsy assay for early detection of oral cancer.
   BMC Cancer. 2026;26:1395.
   PubMed         Abstract available
   
   
8. CHEN Y, Han T, Xi X, Chen D, et al
   Integrated genomic analysis of tumor mutational burden reveals heterogeneous immunotherapy outcomes in head and neck cancer.
   BMC Cancer. 2026;26:1383.
   PubMed         Abstract available
   
   
9. BEDAU T, Zander T, Schlosser H, Buttner R, et al
   High tissue factor (CD142) expression identifies a poor-prognosis subgroup of esophageal and esophagogastric junction adenocarcinoma.
   BMC Cancer. 2026;26:1379.
   PubMed         Abstract available
   
   
10. JI H, Zhang P, Wang Y, Su Y, et al
    Pre-treatment serum bicarbonate predicts survival in patients with locally advanced esophageal squamous cell carcinoma undergoing definitive radiotherapy: a retrospective propensity score matching study.
    BMC Cancer. 2026;26:1390.
    PubMed         Abstract available
    
    
11. LV Y, Zheng D, Zhou Z, Dai Z, et al
    Prognostic evaluation of stage I-IVa nasopharyngeal carcinoma: integrating PET/CT parameters, inflammatory and clinical features.
    BMC Cancer. 2026;26:1398.
    PubMed         Abstract available
    
    
12. CHEN Y, Huang C, Qin Y, Jian Y, et al
    Microbial dysbiosis and treatment-related gastrointestinal adverse events in locoregionally advanced nasopharyngeal carcinoma: an exploratory study of the oral and gut microbiome.
    BMC Cancer. 2026;26:1400.
    PubMed         Abstract available
    
    

    
    BMC Surg

13. NGUYEN XH, Nguyen XH, Nguyen NT, Le Van Q, et al
    Application of continuous intraoperative neuromonitoring (C-IONM) for recurrent laryngeal nerve preservation in transoral endoscopic thyroidectomy: a preliminary report from Vietnam.
    BMC Surg. 2026;26:764.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

14. ZOLKIND P, Wilkerson EM, Panda H, Chembo J, et al
    Targeting DHFR to suppress one-carbon metabolism and enhance radiation sensitivity in patients with NRF2-active head and neck squamous cell carcinoma.
    Clin Cancer Res. 2026 Nov 11. doi: 10.1158/1078-0432.CCR-26-0700.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

15. TAN Q, Luo Y, Liu X, Chen X, et al
    Bilateral Renal Metastases From Esophageal Squamous Cell Carcinoma During Immune Maintenance Therapy on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 Nov 11. doi: 10.1097/RLU.0000000000006775.
    PubMed         Abstract available
    
    
16. RAHMAN A, Bambhroliya P, Agrawal K, Parida GK, et al
    Renal Metastasis From Follicular Thyroid Carcinoma: Concordant FDG and Radioiodine Avidity.
    Clin Nucl Med. 2026 Nov 9. doi: 10.1097/RLU.0000000000006782.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

17. JOSHI KS, Patel M, Steele K, Pitkin L, et al
    Snare-assisted suspension during rigid endoscopic resection of a pedunculated esophageal lipoma.
    Dis Esophagus. 2026;39:doag132.
    PubMed         Abstract available
    
    
18. GIOVANIS E, Dunn J, Cooney J, Zeki S, et al
    Esophageal squamous papillomas.
    Dis Esophagus. 2026;39:doag127.
    PubMed         Abstract available
    
    
19. 
    Correction to: Association of body composition, tumor-specific assessment, and patient demographics at diagnosis with 90-day and overall survival in esophageal cancer patients in a global population.
    Dis Esophagus. 2026;39:doag122.
    PubMed        
    
    

    
    Head Neck

20. ARDOIN A, Vasudevan SS, Rodrigues KC, Vance CJ, et al
    Mohs vs. Wide Local Excision for Early-Stage (AJCC 0-II) Cutaneous Head and Neck Melanoma: A Meta-Analysis.
    Head Neck. 2026;48:3514-3526.
    PubMed         Abstract available
    
    
21. RAHIM S, Kumari M, Abid E, Hoti RK, et al
    Efficacy and Safety of Cisplatin Versus Carboplatin for Patients With Squamous Cell Carcinoma of Head and Neck: A Systematic Review and Meta-Analysis.
    Head Neck. 2026;48:3501-3513.
    PubMed         Abstract available
    
    
22. LORINI L, Governini E, Di Bello A, Uccella S, et al
    Time to Rethink Pathology Reporting in Adenoid Cystic Carcinoma.
    Head Neck. 2026;48:3495-3500.
    PubMed         Abstract available
    
    
23. BRUCCHI F, Poli F, Sperotto B, Colombo C, et al
    Surgery After Thermal Ablation of Thyroid Nodules: A Systematic Review of Surgical Risk, Strategy and Pathological Findings.
    Head Neck. 2026;48:3480-3494.
    PubMed         Abstract available
    
    
24. JOHANSSON-MALMELING C, Petersson K, Finizia C, Tuomi L, et al
    Self-Reported Dysphagia in Head and Neck Cancer Survivors From Diagnosis to Twelve Months Post Treatment and Predictors for Moderate to Severe Long-Term Dysphagia.
    Head Neck. 2026 Nov 9. doi: 10.1002/hed.70541.
    PubMed         Abstract available
    
    
25. LEONI ER, Abbenante ED, Contrera KJ, Unrue KC, et al
    Current Evidence of Precision Medicine via Multi-Omic Approaches in Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2026 Nov 10. doi: 10.1002/hed.70544.
    PubMed         Abstract available
    
    
26. PELLET A, Agbo-Godeau S, Pouillot W, Brocheriou I, et al
    Malignant Transformation in Oral Lichen Planus and Oral Lichenoid Lesions: A Retrospective Study.
    Head Neck. 2026;48:3233-3243.
    PubMed         Abstract available
    
    
27. KOHLER HF, Vartanian JG, Kowalski LP
    Preoperative Predictors of Close or Compromised Surgical Margins in Patients With Oral Squamous Cell Carcinoma.
    Head Neck. 2026;48:3419-3426.
    PubMed         Abstract available
    
    
28. MENDIS RL, Manzie T, Clark JR, Gupta R, et al
    The Impact of Margin Status Following Surgery for Metastatic Cutaneous Squamous Cell Carcinoma to the Parotid Gland.
    Head Neck. 2026;48:3427-3434.
    PubMed         Abstract available
    
    
29. BYORTH JK, Soule SM, Seliger BJ, Bavier RD, et al
    Ketorolac Use After Head and Neck Free Tissue Transfer Is Not Associated With Increased Flap Complications.
    Head Neck. 2026;48:3393-3398.
    PubMed         Abstract available
    
    
30. BENITES C, Chacko K, Chidarala S, Dziegielewski P, et al
    Maxillofacial Re-Reconstruction of Bony Free Flaps Affected by Osteoradionecrosis: 10-Year Single-Institution Experience.
    Head Neck. 2026;48:3363-3371.
    PubMed         Abstract available
    
    
31. SHANNON N, Yabe TE, Ashford B
    Superior Labial Artery Mucosal Flap (SLAM) for Reconstruction of Major Lower Lip Mucosal Defects.
    Head Neck. 2026;48:3356-3362.
    PubMed         Abstract available
    
    
32. KIM DH, Jang DW, Hwang SH
    Antegrade Versus Retrograde Facial Nerve Dissection in Benign Parotid Surgery: A Systematic Review and Meta-Analysis.
    Head Neck. 2026;48:3344-3355.
    PubMed         Abstract available
    
    
33. KHADERI IM, Strum D, Kandahari N, Odeh AJ, et al
    Timing of Postoperative Radiotherapy and Outcomes in Oropharyngeal Squamous Cell Carcinoma.
    Head Neck. 2026;48:3337-3343.
    PubMed         Abstract available
    
    
34. KOVARIK PD, Iqbal MS, Patil R, Kelly C, et al
    Impact of Soft Palate Involvement on the Outcome of Definitive (Chemo)radiotherapy for Tonsillar Squamous Cell Carcinoma.
    Head Neck. 2026;48:3320-3328.
    PubMed         Abstract available
    
    
35. TRUONG AA, Ho S, Apostolova MKI, Lee RH, et al
    Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With Pembrolizumab.
    Head Neck. 2026;48:3329-3336.
    PubMed         Abstract available
    
    
36. DA SILVA FMA, Mortari GR, Buexm LA, Carvalho RS, et al
    Smoking, Tumor Subsite, and Stage as Predictors of Second Primary Tumors in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Retrospective Cohort Study.
    Head Neck. 2026;48:3299-3308.
    PubMed         Abstract available
    
    
37. AUSTERLITZ J, Radevic A, McAdoo A, Golliday K, et al
    Early Feasibility of Registration of Micro-PET/CT Scans to Annotated 3D Specimen Models.
    Head Neck. 2026;48:3286-3298.
    PubMed         Abstract available
    
    
38. KETSCHAU J, Mohr J, Grabenhorst A, Singer H, et al
    From Nodal Metastasis to Oncologic Recurrence in Tongue and Oral Floor Squamous Cell Carcinoma: Distinct Failure Patterns and Clinicopathological Risk Profiles.
    Head Neck. 2026;48:3244-3253.
    PubMed         Abstract available
    
    
39. DU EY, Mann DS, Zitsch RP, Tassone PT, et al
    Association of Facility Case Volume and Patient Travel Distance With Survival in Laryngeal Squamous Cell Carcinoma.
    Head Neck. 2026;48:3254-3262.
    PubMed         Abstract available
    
    
40. MIRALLIE M, Modesto A, Pajiep M, Vergez S, et al
    Safe Omission of Postoperative Neck Irradiation in Selected pN0 Patients With Locally Advanced Oral Cavity Squamous Cell Carcinoma.
    Head Neck. 2026;48:3277-3285.
    PubMed         Abstract available
    
    

    
    Hum Pathol

41. EMECEN SB, Pehlivanoglu B, Sarioglu S, Aysal A, et al
    Neuroendocrine cell proliferation in gastric and gastroesophageal carcinomas following neoadjuvant therapy: Frequency and association with clinicopathological parameters and prognosis.
    Hum Pathol. 2026;177:106235.
    PubMed         Abstract available
    
    
42. ONAGA R, Sakashita S, Komura D, Nakamura N, et al
    Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow.
    Hum Pathol. 2026;177:106200.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

43. MA X, Wu R, Yi J, Dai J, et al
    TTA-MVUM: A Tumor and Text-Aware Multi-View Mamba Framework for Clinical Target Volume Auto-Segmentation in Nasopharyngeal Carcinoma Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2026 Nov 9:S0360-3016(26)04407.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

44. JIANG W, Ismaila N, Chua ML, Haddad R, et al
    Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma: CSCO and ASCO Joint Guideline.
    J Clin Oncol. 2026 Nov 10:101200JCO2602650. doi: 10.1200/JCO-26-02650.
    PubMed         Abstract available
    
    
45. CHEN YP, Ismaila N, Huang SH, Jiang W, et al
    Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update.
    J Clin Oncol. 2026 Nov 10:101200JCO2602648. doi: 10.1200/JCO-26-02648.
    PubMed         Abstract available
    
    

    
    J Laryngol Otol

46. JONES-ANDERSON N, Mill A, Rushton S, Obara B, et al
    Predicting radiation-induced xerostomia in head and neck cancer: a critical review of radiomics, machine learning and methodological quality.
    J Laryngol Otol. 2026 Nov 9:1-10. doi: 10.1017/S0022215126106112.
    PubMed         Abstract available
    
    

    
    J Nucl Med

47. WOLF JV, Buehler A, Paulus LP, Haney B, et al
    Donor Site Evaluation Using Multispectral Optoacoustic Tomography in Patients with Head and Neck Cancer Who Require Free Flap Transplant Surgery.
    J Nucl Med. 2026 Nov 12:jnumed.126.273209. doi: 10.2967/jnumed.126.273209.
    PubMed         Abstract available
    
    

    
    Oral Oncol

48. YOUNG TC, Yap WK, Chang KP, Lee YC, et al
    Chemoradiotherapy versus radiotherapy as adjuvant treatment for head and neck adenoid cystic carcinoma: a meta-analysis.
    Oral Oncol. 2026;182:108193.
    PubMed         Abstract available
    
    
49. YE T
    Interpreting evidence for response adapted surgery in head and neck cancer.
    Oral Oncol. 2026;183:108207.
    PubMed        
    
    
50. SANTER M, Zelger P, Hartl R, Schmutzler L, et al
    Deep learning on contrast-enhanced computed tomography for parotid tumor classification: Providing crucial diagnostic information beyond clinical and radiologic evaluation.
    Oral Oncol. 2026;182:108122.
    PubMed         Abstract available
    
    
51. TORNAAS S, Wang R, Emblem Moe SE, Fromreide S, et al
    Comparative analysis of human papilloma virus detection methods and prognostic significance of transcriptionally active viral load in oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2026;182:108123.
    PubMed         Abstract available
    
    
52. NG T, Tupu M, Maldonado N, Patel R, et al
    Facial palsy Revealing AR+/HER2+ Parotid carcinoma and the efficacy of HER2-Targeted therapy trastuzumab deruxtecan.
    Oral Oncol. 2026;182:108128.
    PubMed         Abstract available
    
    
53. JABLONSKA IA, Rutkowski TW, Kacorzyk U, Kentnowski M, et al
    Circulating tumor HPV DNA reappearance as an early indicator of recurrence after radiotherapy-based treatment for HPV-associated oropharyngeal cancer: analysis of more than 2000 assessments in 232 patients.
    Oral Oncol. 2026;182:108126.
    PubMed         Abstract available
    
    
54. DE LUCA P, Salzano G, Simone M, Petruzzi G, et al
    Major salivary gland carcinomas: A 21-center cohort study of 892 patients with external validation of the UICC 9th edition n-classification.
    Oral Oncol. 2026;182:108136.
    PubMed         Abstract available
    
    
55. ALSULAMI S, Ruhle A, Yu E, Su J, et al
    Validation of the ninth edition pathological and clinical TNM classifications for salivary gland carcinoma.
    Oral Oncol. 2026;182:108140.
    PubMed         Abstract available
    
    
56. OKUDA A, Funayama N, Hata K, Sugiyama M, et al
    Targeting the lactate receptor GPR81 suppresses tumor progression by disrupting glycolytic metabolism in oral squamous cell carcinoma.
    Oral Oncol. 2026;182:108188.
    PubMed         Abstract available
    
    
57. MOLL MCM, Karssemakers LHE, Braun LMM, van Alphen MJA, et al
    Consensus on current clinical workflow and future use of 3D models in parotid gland tumor surgery: A Delphi study.
    Oral Oncol. 2026;182:108163.
    PubMed         Abstract available
    
    
58. BERARDINIS R, Durante S, Riccio S, Vavassori A, et al
    Toward vestibule-specific staging in nasal vestibule squamous cell carcinoma: a single-centre cohort study.
    Oral Oncol. 2026;182:108191.
    PubMed         Abstract available
    
    
59. RAMANAN S, Ashji G, Chadha N, Wu Y, et al
    The double jeopardy effect of socioeconomic barriers on guideline-concordant postoperative radiation in oropharyngeal cancer.
    Oral Oncol. 2026;182:108187.
    PubMed         Abstract available
    
    
60. YANG Q, Zhou M, Zhang C, Lu Y, et al
    Machine learning-based prediction of malignant transformation within 5?years in patients with oral leukoplakia: A retrospective cohort study.
    Oral Oncol. 2026;182:108174.
    PubMed         Abstract available
    
    
61. VAN DER HEIJDEN M, Kommer M, Boers JB, van den Munckhof HAM, et al
    Distinct epigenetic signatures define HPV-positive and HPV-negative tonsil carcinomas.
    Oral Oncol. 2026;182:108186.
    PubMed         Abstract available
    
    
62. LIN X, Han X, Wang M, Shao X, et al
    Treatment pathways for oral tongue or floor of mouth reconstruction: A comparative analysis of islanded facial artery myomucosal flap and free anterolateral thigh flap.
    Oral Oncol. 2026;182:108173.
    PubMed         Abstract available
    
    
63. LI J, Li L, Li H, Xu H, et al
    Differential prognostic value of PD-L1 expression in oropharyngeal squamous cell carcinoma based on HPV status.
    Oral Oncol. 2026;182:108159.
    PubMed         Abstract available
    
    
64. SOLOMON I, Lee J, Pham T, Pauley A, et al
    Surgical salvage improves survival for recurrent oral cavity and oropharyngeal squamous cell carcinoma in the era of immunotherapy.
    Oral Oncol. 2026;182:108161.
    PubMed         Abstract available
    
    
65. MANDUCHI B, Flamand Y, Ferris RL, Quon H, et al
    Prognostic value of baseline modified barium swallow for perioperative dysphagia in oropharyngeal cancer: Secondary analysis of ECOG-ACRIN E3311.
    Oral Oncol. 2026;182:108162.
    PubMed         Abstract available
    
    
66. NAIR S, Inchanalkar M, Chavdaa R, Joshi A, et al
    Effect of erlotinib and celecoxib as short-course neoadjuvant therapy in operable oral cavity squamous cell carcinoma: a randomized controlled window-of-opportunity trial.
    Oral Oncol. 2026;182:108156.
    PubMed         Abstract available
    
    
67. SINGH S, Demircioglu DC, Akakpo KE, Awan M, et al
    Limited benefit of surgical resection for oral cavity squamous cell carcinoma in patients with severe comorbidities.
    Oral Oncol. 2026;182:108153.
    PubMed         Abstract available
    
    
68. NEMADE H, Thaduri A, Gondi JT, Chava SK, et al
    Development of a nodal burden-extranodal extension classification for pathological nodal staging in oral cavity squamous cell carcinoma.
    Oral Oncol. 2026;182:108139.
    PubMed         Abstract available
    
    
69. NYIRJESY SC, de Groot ECM, Chang YS, Romo LV, et al
    Accuracy of radiographic nodal counts in HPV-positive oropharyngeal cancer and impact on treatment.
    Oral Oncol. 2026;182:108127.
    PubMed         Abstract available
    
    
70. TUBIN F, Esemezie AO, Sarkis LM, Yao CM, et al
    Investigating the impact of margins on the management of oropharyngeal cancer treated with transoral robotic surgery: a survey of head and neck oncologists' treatment patterns.
    Oral Oncol. 2026;182:108124.
    PubMed         Abstract available
    
    
71. DAHLSTROM KR, Sazak Kundi FC, Wang RY, Hanania AN, et al
    Demographics, clinical features, and survival of patients with adenoid cystic carcinoma in major and minor salivary glands versus non-salivary sites: an updated SEER analysis.
    Oral Oncol. 2026;182:108149.
    PubMed         Abstract available
    
    
72. LUO S, Xu X, He D, Yang J, et al
    Metastatic SMARCA4-deficient undifferentiated tumor involving the gingiva.
    Oral Oncol. 2026;182:108148.
    PubMed         Abstract available
    
    
73. KARPINETS TV, Mitani Y, Spiotto MT, Li J, et al
    Paired analysis of primary adenoid cystic carcinoma and derived cell lines reveals a mesenchymal and stem-like shift associated with therapy resistance.
    Oral Oncol. 2026;182:108138.
    PubMed         Abstract available
    
    
74. CHARTERS E, Cardoso R, Clark JR, McMillan H, et al
    Assessment, diagnosis, severity, and considerations for phenotype classification of trismus: a systematic review.
    Oral Oncol. 2026;182:108147.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

75. HO F, Jacobs M, Heising L, Cremers P, et al
    Optimising proton therapy referral pathways for lung and oesophageal cancer in a Dutch interorganisational referral network: A canonical action research study.
    Radiother Oncol. 2026;225:111796.
    PubMed         Abstract available
    
    
76. KROMMENHOEK KB, Hol MLF, van der Aa N, Suttie M, et al
    Dose-effect analysis of late dental adverse effects following radiation therapy in survivors of paediatric head and neck rhabdomyosarcoma.
    Radiother Oncol. 2026;225:111820.
    PubMed         Abstract available
    
    
77. ARAMAKI S, Dubail M, Sertorio M, Rahman MM, et al
    Selective lipid metabolic remodelling in radiosensitive normal tissues after FLASH radiotherapy.
    Radiother Oncol. 2026;225:111825.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum